Patents by Inventor Logan Stark

Logan Stark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OCULAR INSERT COMPOSITION OF A SEMI-CRYSTALLINE OR CRYSTALLINE PHARMACEUTICALLY ACTIVE AGENT
    Publication number: 20220331336
    Abstract: The present disclosure includes compositions of a semi-crystalline or crystalline pharmaceutically active agent dispersed in a polymer matrix, in which the active agent is less degraded and, therefore, has lower level of impurities. The present disclosure further includes a method of reducing or preventing physical and chemical degradation of a semi-crystalline or crystalline active agent pharmaceutically active agent dispersed in a polymer matrix. A method of preparation of the composition is also included in this disclosure.
    Type: Application
    Filed: December 6, 2021
    Publication date: October 20, 2022
    Inventors: Logan Stark, Rachna Jain, Ravi Srinivasan, Cary J. Reich, Carlos Schuler
  • BIMATOPROST OCULAR SILICONE INSERTS AND METHODS OF USE THEREOF
    Publication number: 20220331335
    Abstract: The present invention is directed to compositions of bimatoprost, processes of preparing these compositions, devices comprising these compositions, and methods of lowering intraocular pressure.
    Type: Application
    Filed: November 24, 2021
    Publication date: October 20, 2022
    Inventors: Cary J. Reich, Carlos Schuler, Qiang Ye, Logan Stark, Rachna Jain
  • Ocular insert composition of a semi-crystalline or crystalline pharmaceutically active agent
    Patent number: 11224602
    Abstract: The present disclosure includes compositions of a semi-crystalline or crystalline pharmaceutically active agent dispersed in a polymer matrix, in which the active agent is less degraded and, therefore, has lower level of impurities. The present disclosure further includes a method of reducing or preventing physical and chemical degradation of a semi-crystalline or crystalline active agent pharmaceutically active agent dispersed in a polymer matrix. A method of preparation of the composition is also included in this disclosure.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: January 18, 2022
    Assignee: ForSight Vision5, Inc.
    Inventors: Logan Stark, Rachna Jain, Ravi Srinivasan, Cary J. Reich, Carlos Schuler
  • Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
    Publication number: 20190142842
    Abstract: The present disclosure includes compositions of a semi-crystalline or crystalline pharmaceutically active agent dispersed in a polymer matrix, in which the active agent is less degraded and, therefore, has lower level of impurities. The present disclosure further includes a method of reducing or preventing physical and chemical degradation of a semi-crystalline or crystalline active agent pharmaceutically active agent dispersed in a polymer matrix. A method of preparation of the composition is also included in this disclosure.
    Type: Application
    Filed: January 9, 2019
    Publication date: May 16, 2019
    Inventors: Logan Stark, Rachna Jain, Ravi Srinivasan, Cary J. Reich, Carlos Schuler
  • Bimatoprost Ocular Silicone Inserts and Methods of Use Thereof
    Publication number: 20180092926
    Abstract: The present invention is directed to compositions of bimatoprost, processes of preparing these compositions, devices comprising these compositions, and methods of lowering intraocular pressure.
    Type: Application
    Filed: October 4, 2017
    Publication date: April 5, 2018
    Inventors: Cary J. Reich, Carlos Schuler, Qiang Ye, Logan Stark, Rachna Jain
  • Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
    Publication number: 20160296532
    Abstract: The present disclosure includes compositions of a semi-crystalline or crystalline pharmaceutically active agent dispersed in a polymer matrix, in which the active agent is less degraded and, therefore, has lower level of impurities. The present disclosure further includes a method of reducing or preventing physical and chemical degradation of a semi-crystalline or crystalline active agent pharmaceutically active agent dispersed in a polymer matrix. A method of preparation of the composition is also included in this disclosure.
    Type: Application
    Filed: April 12, 2016
    Publication date: October 13, 2016
    Inventors: Logan Stark, Rachna Jain, Ravi Srinivasan, Cary J. Reich, Carlos Schuler
  • Formulations and Methods for Increasing or Reducing Mucus
    Publication number: 20160243291
    Abstract: The present disclosure is directed to a pharmaceutical delivery device useful for the treatment of ocular diseases and disorders through sustained release of therapeutic doses of a pharmaceutical agent, while increasing or reducing formation and/or accumulation of mucus.
    Type: Application
    Filed: October 13, 2014
    Publication date: August 25, 2016
    Inventors: Cary J. Reich, K. Angela Macfarlane, Yair Alster, Logan Stark
  • Bimatoprost Ocular Silicone Inserts and Methods of Use Thereof
    Publication number: 20160022695
    Abstract: The present invention is directed to compositions of bimatoprost, processes of preparing these compositions, devices comprising these compositions, and methods of lowering intraocular pressure.
    Type: Application
    Filed: March 27, 2014
    Publication date: January 28, 2016
    Inventors: Cary Reich, Carlos Schuler, Qiang Ye, Logan Stark, Rachna Jain